Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
52,914,687
-
Share change
-
-2,420,543
-
Total reported value
-
$6,548,838,448
-
Put/Call ratio
-
148%
-
Price per share
-
$123.96
-
Number of holders
-
404
-
Value change
-
-$430,251,147
-
Number of buys
-
209
-
Number of sells
-
185
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q4 2018
As of 31 Dec 2018,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
404 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
52,914,687 shares.
The largest 10 holders included
Vanguard Group Inc, FMR LLC, BlackRock Inc., PUTNAM INVESTMENTS LLC, JPMORGAN CHASE & CO, Bank of New York Mellon Corp, STATE STREET CORP, TIAA CREF INVESTMENT MANAGEMENT LLC, Boston Partners, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
405
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.